Alto Neuroscience Inc. (ANRO)
NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ANRO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $922.97M
- EPS (TTM)
- -$2.31
- Dividend yield
- None
- 52-week range
- 5.23 – 37.48
- Day range
- 23.33 – 24.40
- Volume / Avg
- 346.25K / 548.48K
- Beta
- —
- Shares outstanding
- 39.24M
- Next earnings
- Nov 11, 2026
52-week range
ANRO stock today
Shares of Alto Neuroscience (ANRO) finished lower on Oct 7 at $23.52, a drop of 0.72% or $0.17 per share, versus the S&P 500's 0.22% decline. At this level, ANRO sits in the middle of its 52-week range of $5.23 to $37.48: 37.2% below the high, set on Aug 25, 2026 and 350.1% above the low. ANRO is up 32.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 296.0%.
Alto Neuroscience has posted a net loss over the last twelve months (EPS of -$2.31), so its P/E ratio is not meaningful. Alto Neuroscience's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Alto Neuroscience
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 11, 2026
Alto Neuroscience peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics Class A | 10.77 | -1.64% | $916.60M | vs ANRO |
| KURAKura Oncology Inc. | 10.67 | +1.33% | $949.21M | vs ANRO |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs ANRO |
| SPTXSeaport Therapeutics Inc. | 17.93 | +3.22% | $959.80M | vs ANRO |
| RIGLRigel Pharmaceuticals Inc. | 47.99 | +4.08% | $896.45M | vs ANRO |
| CYRXCryoPort Inc. | 17.35 | -2.53% | $878.76M | vs ANRO |
| ALMSAlumis Inc. | 6.77 | -2.31% | $876.28M | vs ANRO |
| JBIOJade Biosciences Inc. | 13.77 | +2.68% | $875.74M | vs ANRO |
Indexes, lists and sector
Alto Neuroscience stock FAQ
What is Alto Neuroscience's stock price today?
ANRO last traded at $23.52 as of Oct 7, 4:00 PM EDT, down 0.72% on the day. Prices are delayed at least 15 minutes.
When is Alto Neuroscience's next earnings date?
Alto Neuroscience is expected to report earnings on Wednesday, November 11, 2026.
What is the ANRO 52-week high?
The 52-week high for ANRO is $37.48 and the 52-week low is $5.23. The stock is currently 37.2% below its high.